These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36927958)

  • 21. The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-series.
    Chan TY; De Zan V; Gregg A; Alagaratnam J; Gerevini S; Antinori A; D'Arminio Monforte A; Saracino A; Trunfio M; Everitt A; Rackstraw S; Marta M; Calcagno A; Cinque P; Winston A
    AIDS; 2021 Nov; 35(14):2341-2346. PubMed ID: 34127578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse of Symptomatic Cerebrospinal Fluid HIV Escape.
    Ferretti F; De Zan V; Gerevini S; Turrini F; Boeri E; Gianotti N; Hasson H; Lazzarin A; Cinque P
    Curr HIV/AIDS Rep; 2020 Oct; 17(5):522-528. PubMed ID: 32875516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in human immunodeficiency virus-1C viral load and drug resistance mutation between plasma and cerebrospinal fluid in patients with human immunodeficiency virus-associated cryptococcal meningitis in Botswana.
    Kelentse N; Moyo S; Mogwele M; Lechiile K; Moraka NO; Maruapula D; Seatla KK; Esele L; Molebatsi K; Leeme TB; Lawrence DS; Musonda R; Kasvosve I; Harrison TS; Jarvis JN; Gaseitsiwe S
    Medicine (Baltimore); 2020 Oct; 99(41):e22606. PubMed ID: 33031315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance.
    Spudich S; Robertson KR; Bosch RJ; Gandhi RT; Cyktor JC; Mar H; Macatangay BJ; Lalama CM; Rinaldo C; Collier AC; Godfrey C; Eron JJ; McMahon D; Jacobs JL; Koontz D; Hogg E; Vecchio A; Mellors JW
    J Clin Invest; 2019 Jul; 129(8):3339-3346. PubMed ID: 31305262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of cerebrospinal fluid virological escape in patients on long-term protease inhibitor monotherapy.
    Arenas-Pinto A; Stöhr W; Clarke A; Williams I; Beeching NJ; Minton J; Lee V; Paton NI;
    Antivir Ther; 2017; 22(6):535-538. PubMed ID: 28234235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
    Hagberg L; Price RW; Zetterberg H; Fuchs D; Gisslén M
    PLoS One; 2020; 15(7):e0236162. PubMed ID: 32697807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
    Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
    Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
    Damas J; Ledergerber B; Nadin I; Tarr PE; Stoeckle M; Kunze U; Hauser C; Gutbrod K; Calmy A; Assal F; Schmid P; Hundsberger T; Di Benedetto C; Rossi S; Hasse B; Schlosser L; Du Pasquier R; Darling KEA; Cavassini M;
    AIDS; 2021 Dec; 35(15):2469-2480. PubMed ID: 34411034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy.
    Canestri A; Lescure FX; Jaureguiberry S; Moulignier A; Amiel C; Marcelin AG; Peytavin G; Tubiana R; Pialoux G; Katlama C
    Clin Infect Dis; 2010 Mar; 50(5):773-8. PubMed ID: 20100092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
    Peluso MJ; Ferretti F; Peterson J; Lee E; Fuchs D; Boschini A; Gisslén M; Angoff N; Price RW; Cinque P; Spudich S
    AIDS; 2012 Sep; 26(14):1765-74. PubMed ID: 22614889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.
    Barco A; Orlando S; Stroffolini G; Pirriatore V; Lazzaro A; Vai D; Guastamacchia G; Noce G; Atzori C; Trunfio M; Bonora S; Di Perri G; Calcagno A
    J Neurovirol; 2022 Apr; 28(2):226-235. PubMed ID: 35044644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.
    Dahl V; Peterson J; Fuchs D; Gisslen M; Palmer S; Price RW
    AIDS; 2014 Sep; 28(15):2251-8. PubMed ID: 25022595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia.
    Motta I; Allice T; Romito A; Ferrara M; Ecclesia S; Imperiale D; Ghisetti V; Di Perri G; Bonora S; Calcagno A
    Antivir Ther; 2017; 22(6):539-543. PubMed ID: 28198350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV.
    Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M; Guastamacchia G; Bonora S; Di Perri G; Calcagno A
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):169-182. PubMed ID: 37166552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid viral escape in HIV patients on antiretroviral therapy: A systematic review of reported cases.
    Nyondo GG; Njiro BJ; Bwire GM
    Rev Med Virol; 2024 May; 34(3):e2536. PubMed ID: 38578230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India.
    Dravid AN; Natrajan K; Kulkarni MM; Saraf CK; Mahajan US; Kore SD; Rathod NM; Mahajan US; Wadia RS
    Medicine (Baltimore); 2018 Feb; 97(8):e9969. PubMed ID: 29465595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic CSF HIV Escape in Patients on Anti Retroviral Therapy - A Case Series from India.
    Arora S; Dudani S
    J Assoc Physicians India; 2020 Aug; 68(8):47-51. PubMed ID: 32738841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
    Christo PP; Greco DB; Aleixo AW; Livramento JA
    BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.
    Nightingale S; Geretti AM; Beloukas A; Fisher M; Winston A; Else L; Nelson M; Taylor S; Ustianowski A; Ainsworth J; Gilson R; Haddow L; Ong E; Watson V; Leen C; Minton J; Post F; Pirmohamed M; Solomon T; Khoo S
    J Neurovirol; 2016 Dec; 22(6):852-860. PubMed ID: 27194435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.